ArticleMolecular cancer therapeutics2017

Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.

Lisa Giulino-Roth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.